Up to 30% of patients with treatment-resistant schizophrenia treated with clozapine have residual

positive symptoms. Clozapine augmentation is a common approach, but the evidence supporting
this practice is limited.
According to the latest evidence, risperidone, lamotrigine, topiramate, or ECT are potential
augmenting options.
Download this PDF

We are now at the tail end of the algorithm. What do you do if even clozapine has not produced a
satisfactory response? Node 4, clozapine augmentation.
Up to 30% of people with refractory schizophrenia treated with clozapine exhibit residual positive
symptoms. So what to do? Clozapine augmentation is a common approach. Unfortunately, positive
evidence supporting augmentation is very limited.

Before considering clozapine augmentation, you should do a number of things. First, reevaluate
your diagnosis. Be sure you still think you have treatment-resistant schizophrenia. It’s possible that
you have a severe case of schizoaffective disorder or bipolar disorder with psychotic features.
Potential comorbid substance abuse could certainly be undermining all your meds from working
and vigorous attempts to treat that problem should occur. Medication adherence certainly could be
getting in the way of completing your adequate trials and determining if anything can really work
for this patient.
What augmentations do we have? Risperidone and lamotrigine are the best studied options. Each
has five placebo-controlled randomized trials. In the citations I offer you, those are both meta-
analyses of the five trials respectively of those two options. The result of those meta-analyses was
that neither had impressive efficacy. They were reasonably well tolerated, so not unreasonable to
try. At least some of the studies in each cluster of studies were positive. Others were negative. The
studies that had risperidone dose over 4 mg, it seemed to do better than the idea of low dose
risperidone. Just add a little bit of a strong D2 blocking antipsychotic to the clozapine. That did not
work. In fact, maybe the placebo was better. But full dose risperidone did seem to work at least in
one of the studies. So if you are going to risperidone, I would do that. Lamotrigine also had a mixed
bag in terms of the studies. There was one very positive study and the others were all unimpressive.
In fact, one of the literature reviewers said that the study that was positive was such an unbelievable
outlier that they felt it should be removed from the meta-analysis, in which case they concluded
very solidly that lamotrigine did nothing. But I would prefer to have some hope and believe that
maybe there’s something about the patients in that positive study that might apply to some of your
patients. So it’s one of the things that you could try.

What else do we have beside those two best studied options? We have ECT. ECT added to ongoing
clozapine. We have one study where they had clozapine alone as a control and many case reports
of positive results with ECT and clozapine. Those are moderately impressive, except that there was
a study published where they did a sham-controlled trial of ECT in clozapine-treated patients. There
was another, one group where they did everything in a group of patients, putting them under
anesthesia, putting them to sleep, bringing them back to the recovery room, back to the ward. Just
no ECT. And in that study, the ECT had no efficacy. So that was a head scratcher. Anyway, ECT
is on our list of things you could consider as an augmentation with a 2017 hiccup as far as how
enthusiastic we can be about it.
And a final option would be topiramate. There have been a number of meta-analyses because
there’s been a lot of interest in topiramate for weight loss in patients on clozapine and also on other
antipsychotics like olanzapine with weight gain where it has efficacy for weight loss. They also
measured psychopathology in a lot of these studies. When you meta-analyze those aspects of the
studies, there seemed to be some reduction in schizophrenia primary positive symptoms while they
were on topiramate. So I think that deserves inclusion among the augmentations that you could
consider for clozapine when the response is unsatisfactory.

So in summary on clozapine augmentation, you can try it but the evidence is weak and the options
are risperidone, lamotrigine, topiramate or ECT.

References
1. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J. A prospective
study of clozapine in treatmentresistant schizophrenic patients. I. Preliminary report.
Psychopharmacology (Berl) 1989;99 suppl:S68Y72.
2. Buckley P, Miller A, Olsen J, Garver D, Miller DD, Csernansky J. When symptoms
persist: clozapine augmentation strategies. Schizophr Bull 2001;27:615Y28
3. Moore TA, Buchanan RW, Buckley PF, et al. The Texas Medication Algorithm Project
antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry 2007;68:
1751Y62
4. Tiihonen J, Wahlbeck K, Kiviniemi V. The efficacy of lamotrigine in clozapine-
resistant schizophrenia: a systematic review and meta-analysis. Schizophr Res
2009;109: 10Y4
 5. Weiner E, Conley RR, Ball MP, et al. Adjunctive risperidone for partially responsive
people with schizophrenia treated with clozapine. Neuropsychopharmacology
2010;35:2274Y83.
6. Petrides, G., et al (2014). Electroconvulsive therapy augmentation in clozapine-resistant
schizophrenia: a prospective, randomized study. American Journal of Psychiatry,
172(1), 52-58.
7. Havaki-Kontaxaki, B. J., (2006). Concurrent administration of clozapine and
electroconvulsive therapy in clozapine-resistant schizophrenia. Clinical
neuropharmacology, 29(1), 52-56.
8. Melzer-Ribeiro, Debora Luciana, et al. “Efficacy of electroconvulsive therapy
augmentation for partial response to clozapine: a pilot randomized ECT–sham
controlled trial.” Archives of Clinical Psychiatry (São Paulo) 44.2 (2017): 45-50.
9. Hahn, Margaret K., et al. Topiramate in schizophrenia: a review of effects on
psychopathology and metabolic parameters. Clinical schizophrenia & related psychoses
6.4 (2013): 186-196.

Published in: Antipsychotics, Featured, Lamotrigine, Risperidone, Topiramate

Earn CME/SA credits

 Up to 36 CME credits/year
 Up to 16 SA credits/year
 Download more than 70 videos
 Exclusive updates